Resmed 

$208.01
516
+$0.13+0.06% Today

Statistics

Day High
211
Day Low
205.94
52W High
293.73
52W Low
205.19
Volume
1,569,621
Avg. Volume
-
Mkt Cap
30.3B
P/E Ratio
19.77
Dividend Yield
1.15%
Dividend
2.4

Upcoming

Dividends

1.15%Dividend Yield
Mar 26
$0.6
Dec 25
$0.6
Sep 25
$0.6
Jun 25
$0.53
Mar 25
$0.53
10Y Growth
6.66%
5Y Growth
8.18%
3Y Growth
9.26%
1Y Growth
6.19%

Earnings

30JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
2.32
2.51
2.7
2.89
Expected EPS
2.893305
Actual EPS
N/A

Financials

27.22%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
10.29BRevenue
2.8BNet Income

Analyst Ratings

284.71Average Price Target
The highest estimate is 340.00.
From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RMD. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Koninklijke Philips N.V.
PHG
Mkt Cap24.89B
Philips Respironics, a subsidiary of Philips, competes directly with ResMed in the sleep and respiratory care market, offering CPAP machines, ventilators, and other respiratory products.
Fisher & Paykel Healthcare Limited
FPH.NZ
Mkt Cap0
Fisher & Paykel Healthcare is a leading manufacturer of respiratory care products, including CPAP devices and humidifiers, directly competing with ResMed's product offerings.
Medtronic
MDT
Mkt Cap102.71B
Medtronic offers a range of medical devices that compete with ResMed, particularly in the ventilation and monitoring systems for respiratory conditions.
Boston Scientific
BSX
Mkt Cap83.97B
Boston Scientific competes with ResMed in the medical device sector, particularly in areas of sleep and respiratory care through its various healthcare solutions.
GE Aerospace
GE
Mkt Cap299.35B
General Electric, through its healthcare division, provides medical devices and technologies that compete with ResMed's offerings, including respiratory care and sleep solutions.
Smith & Nephew
SNN
Mkt Cap13.3B
Smith & Nephew, while primarily known for orthopedics, competes with ResMed through its products in the medical equipment sector, including devices for wound management that can intersect with care for sleep-related conditions.
Stryker
SYK
Mkt Cap112.88B
Stryker competes with ResMed in the broader medical technology and devices market, offering products that can be used in surgical and critical care settings which may overlap with ResMed's market.
Zimmer Biomet
ZBH
Mkt Cap16.05B
Zimmer Biomet, primarily focused on musculoskeletal healthcare, competes with ResMed in the medical device market, offering products that can indirectly affect sleep and respiratory health.
Hologic
HOLX
Mkt Cap16.97B
Hologic offers medical devices and technology that compete with ResMed, particularly in the diagnostics and treatment of sleep disorders through its imaging and digital health solutions.
Intuitive Surgical
ISRG
Mkt Cap162.13B
Intuitive Surgical, known for its robotic surgical systems, competes with ResMed in the broader healthcare technology space, offering innovative solutions that can impact the treatment of conditions related to sleep and respiratory care.

About

There is no Profile data available for RME.SG.
Show more...
CEO
Mr. Michael J. Farrell BE, MBA, SM
Employees
9980
Country
United States
ISIN
US7611521078

Listings

0 Comments

Share your thoughts

FAQ

What is Resmed stock price today?
The current price of RMD is $208.01 USD — it has increased by +0.06% in the past 24 hours. Watch Resmed stock price performance more closely on the chart.
What is Resmed stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Resmed stocks are traded under the ticker RMD.
Is Resmed stock price growing?
RMD stock has fallen by -1.85% compared to the previous week, the month change is a -7.52% fall, over the last year Resmed has showed a -14.03% decrease.
What is Resmed market cap?
Today Resmed has the market capitalization of 30.3B
When is the next Resmed earnings date?
Resmed is going to release the next earnings report on July 30, 2026.
What were Resmed earnings last quarter?
RMD earnings for the last quarter are 2.86 USD per share, whereas the estimation was 2.8 USD resulting in a +2.32% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Resmed revenue for the last year?
Resmed revenue for the last year amounts to 10.29B USD.
What is Resmed net income for the last year?
RMD net income for the last year is 2.8B USD.
Does Resmed pay dividends?
Yes, RMD dividends are paid quarterly. The last dividend per share was 0.6 USD. As of today, Dividend Yield (FWD)% is 1.15%.
How many employees does Resmed have?
As of May 06, 2026, the company has 9,980 employees.
In which sector is Resmed located?
Resmed operates in the Health & Wellness sector.
When did Resmed complete a stock split?
The last stock split for Resmed was on August 31, 2010 with a ratio of 2:1.
Where is Resmed headquartered?
Resmed is headquartered in San Diego, United States.